System Transmission

Top Signal

100#1 JOB

Activity

2181Ripe

+940 today

System

Livenow

Terminal Asset View

stockNASDAQ

MGX

$1.46-7.01%

Metagenomi Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

15Overripe

Live Analysis Active

Company Mission

Metagenomi creates advanced gene-editing technologies that can potentially fix genetic problems in human cells. These tools are used by pharmaceutical companies and research institutions to develop new treatments for genetic diseases. The company makes money by partnering with these organizations, licensing its technology, and collaborating on research projects to advance medical science.

MGX

Industry Context

The biotechnology industry focuses on using biological systems to develop treatments and technologies. Companies in genetic medicine are working on advanced tools to edit DNA, which could potentially treat diseases that currently have no cure. This sector often sees increased attention when scientific breakthroughs occur or when regulatory approvals advance.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

71Matrix

Market Momentum

44.6— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.3x— Normal Volume

Today's Change

-7.01%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing MGX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 12:03 PM UTC

As-of 03-15-2026 11:47 UTC

Develops gene editing tools to treat diseases and makes money by licensing its technology to drug companies.

Price has been coiling in a tight pattern for the past two weeks, suggesting energy building for the next significant move.

Biotech sector showing increased interest in genetic therapies, which could benefit companies developing next-generation editing platforms.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...